No data to show
OTCM
NVLPF
Market cap15mUSD
Jul 28, Last price
0.20USD
1Q
9.94%
IPO
-3.13%
Name
Nova Leap Health Corp
Chart & Performance
P/E
12.54
P/S
0.67
EPS
0.02
Div Yield, %
—
Shrs. gr., 5y
7.54%
Rev. gr., 5y
8.16%
Revenues
26m
-1.60%
Net income
1m
P
CFO
1m
-35.58%
Earnings
Aug 06, 2025
Profile
Nova Leap Health Corp. provides home and home health care services in the United States and Canada. Its services include dementia care, companionship, personal and respite care, cooking and meal preparation, bathing, dressing, grooming, housekeeping, errands, transportation, and medication reminders by nursing staff. Nova Leap Health Corp. was incorporated in 2015 and is headquartered in Halifax, Canada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | 25,761 -1.60% | 26,179 -7.18% | 28,205 32.55% | ||||||
Cost of revenue | 24,313 | 24,834 | 27,911 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | 1,447 | 1,345 | 294 | ||||||
NOPBT Margin | 5.62% | 5.14% | 1.04% | ||||||
Operating Taxes | 434 | 311 | (371) | ||||||
Tax Rate | 29.95% | 23.14% | |||||||
NOPAT | 1,014 | 1,034 | 665 | ||||||
Net income | 1,378 -230.70% | (1,055) 26.20% | (836) -147.47% | ||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 1,788 | ||||||||
BB yield | -9.21% | ||||||||
| Debt | |||||||||
Debt current | 1,623 | 484 | 2,689 | ||||||
Long-term debt | 1,888 | 2,104 | 2,770 | ||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | 2,108 | 1,694 | 4,186 | ||||||
| Cash flow | |||||||||
Cash from operating activities | 1,388 | 2,155 | 1,021 | ||||||
CAPEX | (25) | (28) | (71) | ||||||
Cash from investing activities | (1,591) | (23) | (56) | ||||||
Cash from financing activities | 730 | (2,516) | (1,414) | ||||||
FCF | 1,468 | 2,099 | 1,054 | ||||||
| Balance | |||||||||
Cash | 1,403 | 895 | 1,273 | ||||||
Long term investments | |||||||||
Excess cash | 115 | ||||||||
Stockholders' equity | 15,940 | 15,934 | 16,551 | ||||||
Invested Capital | 20,660 | 19,595 | 22,649 | ||||||
ROIC | 5.04% | 4.90% | 2.85% | ||||||
ROCE | 6.97% | 6.87% | 1.30% | ||||||
| EV | |||||||||
Common stock shares outstanding | 87,528 | 86,209 | 77,654 | ||||||
Price | 0.27 -10.00% | 0.30 20.00% | 0.25 -59.02% | ||||||
Market cap | 23,633 -8.62% | 25,863 33.22% | 19,413 -59.02% | ||||||
EV | 25,740 | 27,557 | 23,600 | ||||||
EBITDA | 2,031 | 2,230 | 1,650 | ||||||
EV/EBITDA | 12.67 | 12.36 | 14.31 | ||||||
Interest | 107 | 271 | |||||||
Interest/NOPBT | 7.38% | 92.23% | |||||||